Product NDC: | 54973-1069 |
Proprietary Name: | BIOCHEMIC PHOSPHATE |
Non Proprietary Name: | TRIBASIC CALCIUM PHOSPHATE, FERROSOFERRIC PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, and SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE |
Active Ingredient(s): | 3; 3; 3; 3; 3 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; TRIBASIC CALCIUM PHOSPHATE, FERROSOFERRIC PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, and SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54973-1069 |
Labeler Name: | Hyland's |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 19790919 |
Package NDC: | 54973-1069-2 |
Package Description: | 1000 TABLET in 1 BOTTLE, PLASTIC (54973-1069-2) |
NDC Code | 54973-1069-2 |
Proprietary Name | BIOCHEMIC PHOSPHATE |
Package Description | 1000 TABLET in 1 BOTTLE, PLASTIC (54973-1069-2) |
Product NDC | 54973-1069 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | TRIBASIC CALCIUM PHOSPHATE, FERROSOFERRIC PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, and SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19790919 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Hyland's |
Substance Name | FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE |
Strength Number | 3; 3; 3; 3; 3 |
Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharmaceutical Classes |